Kewpie PEG
The PEG Ratio (Price/Earnings-to-Growth) of Kewpie (2809.T) as of Jul 31, 2026 is 0.86. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.23 — a change of -29.79% (lower).
Get this data via API
Financial Data API
PEG
0.86
YoY
-29.79%
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of Kewpie is 2026 0.86 . PEG Ratio (Price/Earnings-to-Growth) of Kewpie was 2025 1.23 . It decreases by -29.79% lower compared to the previous year.
Access this data via the Eulerpool API
Kewpie Stock analysis
What does Kewpie do? Kewpie Corp is a Japanese company known for its mayonnaise-like dressings that are sold worldwide. The company was founded in Tokyo in 1919 and has since become a leading manufacturer of food and pharmaceutical products in Japan.
The history of Kewpie began in the 1910s when the Japanese government sought to increase egg demand. Kewpie developed a version of mayonnaise made from pureed eggs and vinegar, which had a mild, sweet taste.
Kewpie quickly gained popularity, and in the 1920s, the company expanded its production and began producing a wider range of food and health products. The company was converted to a joint stock company in 1949 and listed on the Tokyo Stock Exchange in 1962.
Kewpie specializes in two areas: food and pharma. The food division is divided into various business segments, including dressings and sauces, dairy products, ready-to-eat meals, and confectionery. Kewpie is known for its mayonnaise-like dressings, such as "Kewpie Mayonnaise." The dressings are offered in a variety of flavors, from classic to exotic, and are available in many countries around the world. Kewpie's dairy products include various types of yogurt, cheese, and milk powder, while the ready-to-eat meals include various types of instant noodles and soups. The confectionery division offers chocolate, cakes, and snacks.
Kewpie's pharma division focuses on the development and production of high-quality active ingredients and products from plant-based raw materials. The company utilizes its expertise in food production to process plant-based raw materials and make the active ingredients medically usable. Kewpie's products operate in several therapeutic areas, such as cardiovascular diseases, diabetes, and cancer.
Another notable division of Kewpie is the cosmetics area. The company has developed a line of skincare products based on plant-based raw materials that have gained trust through their quality. The company focuses on developing natural products with ingredients that promote skin health.
In recent years, Kewpie has aimed to increase its innovation power to bring products to the market that meet consumer needs. Innovative technologies are applied to achieve new formulations and packaging designs. Kewpie has expanded its ability to innovate and offers its customers products that they will not find anywhere else. Another revolution that the company has achieved is the packaging-free concept, in which Kewpie offers products in reusable containers to contribute to reducing future waste.
With its rich history and ability to focus on consumer needs and bring innovative products to the market, Kewpie has achieved a strong position in the food and pharma sectors. The company is committed to continuing its growth and becoming even stronger by continuing to offer products that provide new experiences to customers. Kewpie is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Kewpie stock
PEG Ratio (Price/Earnings-to-Growth) of Kewpie is 0.86 in 2026.
Access this data via the Eulerpool API
Valuation — Kewpie
All Key Metrics — Kewpie
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth